UK markets close in 7 hours 44 minutes

Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
36.22-0.34 (-0.93%)
As of 08:00AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 760.16M
Enterprise value 748.47M
Trailing P/E 25.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.09
Price/book (mrq)3.43
Enterprise value/revenue 3.04
Enterprise value/EBITDA 12.54

Trading information

Stock price history

Beta (5Y monthly) 1.09
52-week change 3-21.59%
S&P500 52-week change 322.64%
52-week high 350.00
52-week low 329.06
50-day moving average 338.29
200-day moving average 337.15

Share statistics

Avg vol (3-month) 3517
Avg vol (10-day) 3376
Shares outstanding 520.83M
Implied shares outstanding 621.24M
Float 814.21M
% held by insiders 131.35%
% held by institutions 129.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 41.37%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 31.37%
5-year average dividend yield 40.94
Payout ratio 434.25%
Dividend date 3N/A
Ex-dividend date 429 May 2024
Last split factor 24:1
Last split date 331 Jul 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 10.69%
Operating margin (ttm)19.10%

Management effectiveness

Return on assets (ttm)6.94%
Return on equity (ttm)13.93%

Income statement

Revenue (ttm)246.09M
Revenue per share (ttm)11.82
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 57.26M
Net income avi to common (ttm)30.01M
Diluted EPS (ttm)1.46
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)68M
Total cash per share (mrq)3.27
Total debt (mrq)56.3M
Total debt/equity (mrq)25.12%
Current ratio (mrq)2.79
Book value per share (mrq)10.67

Cash flow statement

Operating cash flow (ttm)37.7M
Levered free cash flow (ttm)-39.25M